July 24, 2025|
AI
|4 months agoRoche CEO Proposes Direct Drug Sales to Cut US Prices
Swiss pharmaceutical giant Roche suggests eliminating intermediaries could halve US drug prices, marking significant shift in international healthcare pricing strategy.
AI
Generated IllustrationKey Takeaways
AI
- Roche CEO Thomas Schinecker proposes selling drugs directly to US patients to cut prices.
- Roche claims it can reduce US drug prices by 50% by bypassing intermediaries.
- President Trump has threatened the pharmaceutical sector with tariffs of up to 200%.
- Roche plans to invest $50 billion in US manufacturing and R&D.
By The Numbers
50%
Potential price reduction
2.3 times
Price multiplier
CHF 30.9 billion
H1 Sales
CHF 11.1 million
Core diluted EPS
They Said
"So if the US would like to cut prices by 50%, it’s very easy. We go direct."
"We hope that the US government, then also sees... that the companies are intending to produce the medicines that are needed in the US, for the US."
1
The 50% Solution: Slashed Prices via Direct Sales
2
Confronting the 'Zero Risk' Middlemen
3
Trump's Tariff Threat and the Price Gap
4